Institutional Research Information Service
UCL Logo
Please report any queries concerning the funding data grouped in the sections named "Externally Awarded" or "Internally Disbursed" (shown on the profile page) to your Research Finance Administrator. Your can find your Research Finance Administrator at https://www.ucl.ac.uk/finance/research/rs-contacts.php by entering your department
Please report any queries concerning the student data shown on the profile page to:

Email: portico-services@ucl.ac.uk

Help Desk: http://www.ucl.ac.uk/ras/portico/helpdesk
Publication Detail
The use of alternative medical therapies in patients with systemic lupus erythematosus. Trination Study Group
  • Publication Type:
    Journal article
  • Publication Sub Type:
  • Authors:
    Moore AD, Petri MA, Manzi S, Isenberg DA, Gordon C, Senecal JL, St Pierre Y, Joseph L, Penrod J, Fortin PR, Sutcliffe N, Goulet JR, Choquette D, Grodzicky T, Esdaile JM, Clarke AE
  • Publication date:
  • Pagination:
    1410, 1418
  • Journal:
    Arthritis and Rheumatism
  • Volume:
  • Issue:
  • Print ISSN:
  • Keywords:
    ABSENCE, additional, adult, Alternative Medicine, As, BEHAVIOR, Canada, Care, COHORT, Cohort Studies, COMMON, consumption, cost, costs, demographic, disease, economics, Female, Form, future, Great Britain, health, Health Care Costs, Health Resources, Health Status, HEALTH-CARE, HEALTH-STATUS, Id, INSTRUMENT, LEVEL, Lupus Erythematosus, Systemic, Male, May, Methods, Middle Age, Morbidity, NUMBER, Patient, patients, physiopathology, PROBABILITY, Questionnaire, Questionnaires, Social Support, STATE, STATES, support, Support, Non-U.S.Gov't, Support, U.S.Gov't, P.H.S., Survey, therapy, TIME, United States, USERS, utilization
  • Addresses:
    McGill University Health Centre, Montreal, Quebec, Canada
  • Notes:
    UI - 20313945 LA - eng PT - Journal Article ID - P60-AR-4481101/AR/NIAMS ID - R01-AR-43727/AR/NIAMS ID - RR-00722/RR/NCRR ID - etc DA - 20000630 IS - 0004-3591 SB - AIM SB - IM CY - UNITED STATES JC - 90M
OBJECTIVE: As part of an ongoing study of health resource utilization and diminished productivity in patients with systemic lupus erythematosus (SLE), the use of alternative medical therapies was assessed. METHODS: A cohort of 707 patients with SLE from 3 countries completed questionnaires on demographics, social support, health status (using the Short Form 36 health survey), satisfaction with health care, health resource utilization (conventional resources and alternative therapies), and time losses in labor market and non-labor market activities. Annual direct and indirect costs (1997 Canadian dollars) were calculated and compared for users and nonusers of alternative medical therapies. RESULTS: Among the 707 patients, 352 (49.8%) were found to use alternative therapies and at similar rates across Canada, the United States, and the United Kingdom. Users were younger and better educated than nonusers, exhibited poorer levels of self-rated health status and satisfaction with medical care, and had minimal to no objective evidence of worse disease (according to the revised Systemic Lupus Activity Measure instrument). The mean of log direct medical costs for conventional resources was higher for users of select alternative therapies compared with nonusers. In a logistic regression, neither the number of alternative therapies used nor the individual therapy increased the probability of incurring indirect costs. CONCLUSION: The use of alternative medical therapies is common in patients with SLE. Users of many alternative medical therapies accrue greater conventional medical costs compared with nonusers. The use of alternative medical therapy may be a marker for care-seeking behavior associated with higher consumption of conventional medical resources in the absence of demonstrable additional morbidity and should be considered in future cost analyses of patients with SLE
Publication data is maintained in RPS. Visit https://rps.ucl.ac.uk
 More search options
UCL Researchers
University College London - Gower Street - London - WC1E 6BT Tel:+44 (0)20 7679 2000

© UCL 1999–2011

Search by